PharmaTher Holdings Ltd.
PHRRF
$0.135
-$0.0143-9.58%
OTC PK
| 11/30/2024 | 08/31/2024 | 05/31/2024 | 02/29/2024 | 11/30/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 643.50K | 634.80K | 670.20K | 732.70K | 744.60K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.06M | 1.48M | 2.26M | 2.81M | 3.10M |
| Operating Income | -1.06M | -1.48M | -2.26M | -2.81M | -3.10M |
| Income Before Tax | -1.08M | -1.59M | -2.31M | -3.22M | -3.51M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -1.08 | -1.59 | -2.31 | -3.22 | -3.51 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1.08M | -1.59M | -2.31M | -3.22M | -3.51M |
| EBIT | -1.06M | -1.48M | -2.26M | -2.81M | -3.10M |
| EBITDA | -1.06M | -1.48M | -2.26M | -2.81M | -3.10M |
| EPS Basic | -0.01 | -0.02 | -0.03 | -0.04 | -0.04 |
| Normalized Basic EPS | -0.01 | -0.01 | -0.02 | -0.02 | -0.02 |
| EPS Diluted | -0.01 | -0.02 | -0.03 | -0.04 | -0.04 |
| Normalized Diluted EPS | -0.01 | -0.01 | -0.02 | -0.02 | -0.02 |
| Average Basic Shares Outstanding | 353.61M | 353.26M | 352.91M | 352.68M | 352.68M |
| Average Diluted Shares Outstanding | 353.61M | 353.26M | 352.91M | 352.68M | 352.68M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |